Friday, 27 December 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 27 December 2024
News

AZ spearheads cancer funding plan

Posted 20 March 2024 AM

AstraZeneca is spearheading the push for the establishment of an Australian Interim Cancer Fund (ICF) to expedite access to innovative treatments for cancer patients, with a Roundtable to discuss the initiative being held today in Canberra.

Under the plan, medicines would be funded after TGA approval while further data is being collected to support reimbursement through the PBS.

To see the whole article, please login

Popular

Who got booted to the May meet?
Company tops Rotten Tomato list
Best company Christmas gift is...
First out the door in '25?
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home